Developing an Effective Oral Analgesic Regimen

Slides:



Advertisements
Similar presentations
Pain Control in Hospice and Palliative Care
Advertisements

The Management of Incident Pain in Palliative Care.
Opioids and other drugs we use on palliative care
Pain Management Drug Therapy Workshop
Transdermal pain management
Anticipatory prescribing
Syringe Driver Drugs.
AGS THE AMERICAN GERIATRICS SOCIETY Geriatrics Health Professionals.
Pain Management Robert B. Walker, M.D., M.S. DABFP, CAQ (Geriatrics) Robert C. Byrd Center for Rural Health Marshall University.
What to Do About Pain Nirmala Abraham Hidalgo, MD Assistant Director, UCLA Pain Management Center Assistant Professor, Dept. of Anesthesiology UCLA - David.
Opioid Pharmacology: How to choose and how to use Romayne Gallagher MD, CCFP Division of Palliative Providence Health Care.
ACUTE CANCER PAIN Dr Mike Bennett Senior Clinical Lecturer in Palliative Medicine St Gemma’s Hospice and University of Leeds.
Julie Latimer DANA NSW Drug & Alcohol Nurses Forum September 2014.
Pain Management In the Palliative Care Setting M. Thomas Beets MD.
CANCER PAIN MANAGEMENT PAMELA M. SUTTON, M.D. FAAHPM DECEMBER 2013.
Key dosing points: Begin a bowel regimen when opioid therapy is initiated (senna + docusate). For CHRONIC pain, use a scheduled medication regimen. ( ex:
Calvin Lui, MD PGY2 February 8,  Common Opioid Agents and Good Starting Dosages  Opioid Conversion  Use of Patient Controlled Analgesia and Good.
Pain Policy Update Opioid Update Stuart Beatty, PharmD, BCPS.
Medical-Surgical Nursing: An Integrated Approach, 2E Chapter 14
Copyright © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 05: Relieving Pain and Providing Comfort.
You can control pain Module 9. Learning objectives ■ Describe the 3 steps of the analgesic ladder ■ Give examples of drugs from each step of the ladder.
A Practical Approach to Cancer Pain Management
Copyright © 2015 Cengage Learning® 1 Chapter 19 Analgesics, Sedatives, and Hypnotics.
August 16, 2015 Equianalgesia Opioid Calculator: JHH Applications Suzanne A Nesbit, PharmD, CPE Clinical Pharmacy Specialist, Pain Management Department.
Comfort Ch 41. Pain Considered the 5 th Vital Sign Considered the 5 th Vital Sign Is what the patient says it is Is what the patient says it is.
UMMS CRIT Module II: Opioid Usage in Older Adults Catherine DuBeau, MD Clinical Director of Geriatrics UMMS.
Step two: Moderate pain Tramadol Opioid combinations Acetaminophen or aspirin with Codeine Hydrocodone Oxycodone Plus/minus adjuvants Dose limiting toxicity.
Pain Management In The Hospitalized Patient Presented By R2 顏郁軒 92/09/16.
C C E E N N L L E E Pediatric Palliative Care Analgesics NSAIDs  Cyclooxygenase inhibition leads to interference with production of PGs (Cox-2)  Decreased.
care Presenter: Gwendolyn Buhr, MD long-term care Chronic Pain in the Nursing Home Resident.
The Nervous System CNS BrainSpinal cord PNS Sensory division (afferent) Motor division (efferent) Somatic nervous system (voluntary) Autonomic nervous.
Pharmacotherapy III Fall The International Association for the Study of Pain defines pain as an unpleasant sensory and emotional experience associated.
Acute Pain Management Solomon Liao, M.D. Clinical Professor Director of Palliative Care Service UCI Hospitalist Program.
Katy Trinkley, PharmDAngie Thompson, PharmD.  Opioid risks and risk prevention strategies  Medication treatment by pain type  Fundamental principles.
1 Controlled drug release Dr Mohammad Issa. 2 Frequency of dosing and therapeutic index  Therapeutic index (TI) is described as the ratio of the maximum.
Aging Q3 Pain Management ACOVE  Pharmacological treatment with analgesics for pain is the most common in the elderly, however, the use of alternative medications.
WHO Analgesic Ladder Disclaimer: This presentation contains information on the general principles of pain management. This presentation cannot account.
Treatment: other opioids Disclaimer: This presentation contains information on the general principles of pain management. This presentation cannot account.
Dr. S. Parthasarathy MD., DA., DNB, MD (Acu), Dip. Diab. DCA, Dip. Software statistics PhD (physio) Mahatma Gandhi Medical college and research institute,
Pain II: Cancer Pain Management Dr. Leah Steinberg.
Let’s Talk About Pain Karen Cox-Seignoret M.B.,B.S., M.R.C.G.P.
Dr Barbara Downes June Introduction Patient group An over view of managing pain Revision of the basics Case examples Drugs and conversions in the.
Safe Opioid Prescribing MedicinesDoseFrequencyRouteQuantity Morphine Sulphate MR 10mg tablets10mgBD OralSupply 28 tablets (Twenty eight tablets) Morphine.
Pain Ladder and Opiate Conversion Christopher Haigh Medicines Optimisation Pharmacist Bolton CCG.
Inadequately treated acute pain can lead to prolonged hospital stay, delayed recovery, psychological consequences, increased costs and the development.
Chronic Pain Management Harald Lausen, DO, MA FCM Clerkship SIU School of Medicine.
Dominique A. Lossignola and Cristina Dumitrescu Current Opinion in Oncology 2010, 22:302–306 R2 박소영 /prof. 이재진.
DEBBIE DONELSON, MD Opioid use for nonmalignant pain management.
Medications for Spine Pain
Objectives Palliative pain management in the ER : Basic approach
Opiod analgesics 9월 흉부외과 인턴 김영재.
Section III: Pharmacological Therapies
Acute Pain Management Solomon Liao, M.D.
Palliative Care in the Outpatient Setting: Pain Management
Addressing sleep problems- The role of long-acting opioids
Cancer Pain David Cameron
The WHO Analgesic Ladder
CH 20: PAIN NATIONAL DEPARTMENT OF HEALTH PRIMARY HEALTHCARE 2014
Pain Management: Patients Maintained on Buprenorphine
THE MODERN MANAGEMENT OF PAIN IN PALLIATIVE MEDICINE
Comfort Ch 41.
How do I manage pain and agitation?
ACUTE PAIN MANAGEMENT FOR EMS
Calculating and Using Morphine Equivalent Doses of Opioids
Pain Management Ahmad Abudayyeh.
Malignant pain – management
Pain management (part 2)
Pain and Other Symptom Management
Pain Assessment and Management
Pain Management Top 10 Resident Pitfalls- 2019
Presentation transcript:

Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical Director, Loyola Hospice

General Principles Assess pain thoroughly Know your patient Know the medications Dose to reduce pain by at least 50% Reassess frequently

Pain Pain is a personal, complex experience with 3 components Sensory Emotional Cognitive

Review Neuroscience lectures on pain physiology! P&T lectures on NSAIDs and opiates!

Pain pathophysiology Acute pain Chronic pain identified event, resolves days–weeks usually nociceptive Chronic pain cause often not easily identified, multifactorial indeterminate duration nociceptive and / or neuropathic Somatic pain – body surface tissue or musculoskeletal tissue. Localized, sharp Visceral – not well localized -= visceral do not contain many nociceptors. Result of compression, obstruction, infiltration, ischemia, strethcing, inflammation, or thoracic, abdominal or pelvic visceral Nociceptive pain – results from actual or potential tissue damage. Result of ongoing activation of nociceptors on primary afferent nerves by noxious stimuli Somative vs visceral

WHO 3-Step Ladder Step 3 - Severe Step 2 - Moderate Morphine Hydromorphone Methadone Oxycodone Fentanyl Codeine/… Hydrocodone/… Oxycodone/… …/acetaminophenor NSAID Tramadol Step 1 - Mild Aspirin Acetaminophen NSAIDs Always consider adding an adjuvant Rx

“Adjuvant Analgesic” Drug which has a primary indication other than pain management Acts as analgesic in some painful conditions Antidepressants Corticosteroids Anticonvulsants Local anesthetics Osteoclast inhibitors Radiopharmaceuticals Muscle relaxants Benzodiazepenes

Our Case Continuous pain Moderate intensity Chronic, non-neuropathic Worsens with certain activites

Where to begin? Begin low dose immediate release oral opioid Examples Hydrocodone 5mg Morphine 5mg Oxycodone 3mg Hydromorphone 1mg Hospice and Palliative Care Training for Physicians: UNIPAC 3 Assessment and Treatment of Physical Pain Associated with Life- Limiting Illness, CP Storey et al, ed EPERC, Fast Facts

Community Service Announcement

Opioids vs Narcotics Opioid Narcotic Naturally occurring, semisynthetic, and synthetic drugs which produce effects by combining with opioid receptors and antagonized by nalaxone Narcotic “numbness” or “stupor” Describes morphine like drugs and drugs of abuse (including coca/cocaine derivates)

Opioids vs Narcotics “Who’s got the opioid keys?” “Who’s got the narc keys?” “Who’s got the opioid keys?”

Immediate Release Oral Opioid Administered as single agents combination products Peak analgesic effect occurs in 60-90 minutes Expected total duration of analgesia of 2-4 hours. Standard reference sources generally cite a 4 hour dosing interval for the single-agent opioids 4-6 or 6 hour intervals for combination products Agency for Health Care Policy and Research (AHCPR) Clinical Practice Guideline (1994) recommends dosing intervals for all short-acting opioids at an interval or every 3-4 hours, an interval more consistent with patient reports of pain relief and the half-life of oral opioids.

Combination opiate/nonopiate -50 different opioid combination products Contain either acetaminophen, aspirin or ibuprofen, with an opioid range of tablet strengths and liquids typically used for moderate pain that is episodic For persistent pain administered on around-the-clock basis

Step 2 Opioid Combos Potency Oxycodone > hydrocodone > codeine Propoxyphene = aspirin or acetaminophen The dose limiting property of all the combination products is? aspirin, acetaminophen or NSAID

WHO Step 2 Tramadol Centrally acting synthetic analgesic m-opioid receptor binding Weak inhibition of serotonin uptake Weak inhibition of norepinephrine uptake Cautions: Serotonin syndrome Lowers seizure threshold

Our patient On Percocet Combination opioid/nonopioid Oxycodone/acetaminophen Strengths 2.5/325 5/325 7.5/325 7.5/500 10/325 10/650

Initial Plan Oxycodone/acetaminophen Not helping - still 5-6/10 pain 2.5/325 q 6 hours Not helping - still 5-6/10 pain Titration Increase 25-50% for mild-moderate pain Increase 50-100% for moderate – severe pain Most short acting opiates can be safely titrated every 2 hours Side effect evaluation Sedation

EPIC In-Box Oxycodone/acetaminophen 5/325 tab 1-2 tabs every 6 hours as needed

Case Options? Increase dose of oxycodone/acetaminophen? 10/325 tabs – take 1 ½, not relieved, take 2 Change dosing interval? Q 4 hours Scheduled vs PRN dosing? Scheduled Change to another opiate combo? Oxycodone most potent Change to non-combo opiate? Soon - reaching acetaminophen max Add breakthrough dose of opiate? Yes, but will need an agent without acetaminophen Add an adjuvant? Re-evaluarte characteristics of pain Begin long acting opiate? When stable daily dosage requirements determined

Plan Relief!! Oxycodone 10/325 1 1/2 tabs q 4 hours scheduled 2 days later, a little better, not sleepy 2 tabs q 4hours scheduled Titrated oxycodone from 40mg /24 hours to 120mg/24 hours (acetaminophen 3900mg/24 hours) Relief!!

Q 4 hour ATC meds?

Extended-release opiate preparations Improve compliance, adherence

Extended Release Opiates NEVER!!!!! In opiate naïve patients!!!!!

Extended Release Preparations Extended Release Oral Morphine Extended Release Oral Oxycodone Transdermal Fentanyl

Extended-release opiate preparations Morphine Morphine ER, MS Contin, Kadian, Avinza Oxycodone Oxycodone ER, Oxycontin Fentanyl Transderm patch (Duragesic)

Extended-release opioid preparations Dose q 8, 12, or 24 h (product specific) Don’t crush or chew capsules No capsules down feeding tubes may flush time-release granules (Kadian) down feeding tubes Adjust dose q 2–4 days (once steady state reached) Fentanyl transderm q 72 hours Adjust dose at 6 days (once steady state achieved)

Extended-release opioid preparations Should not be used for rapid titration in patients with severe pain

Case - How? Oxycodone 10/325 Oxycodone ER 60mg q 12 hours 2 tabs q 4 hours 120mg oxycodone/24 hours Oxycodone ER 60mg q 12 hours

Could we use extended release morphine? Could we use transdermal fentanyl?

Fentanyl Lipid soluble -Crosses skin and oral mucosa Transdermal fentanyl 25 mg patch » 45–135 (likely 50–60) mg PO morphine / 24 h 12 mg patch is available now

Fentanyl Transdermal Patch onset after application  24 hours effect 72 hours (some patients 48 hours) ensure adherence to skin increased absorption with increased body temp may not be as effective in cachexia (minimal adipose tissue)

Our patient Convert to Fentanyl Oxycodone 120mg/24 hours

Equianalgesic doses of opioid analgesics po / pr (mg) Analgesic SC / IV / IM (mg) 100 Codeine 60 15 Hydrocodone - 4 Hydromorphone 1.5 15 Morphine 5 10 Oxycodone -

Conversion Oxycodone 120mg x Morphine 15mg =180mg morphine equivalent 25 mg patch » 50 mg PO morphine / 24 h Fentanyl 75mcg/hr patch q 72 hrs

Breakthrough Pain Incident Idiopathic, spontaneous End-of-dose failure Activity related, identifiable precipitant Anticipate and premedicate with short acting agents Idiopathic, spontaneous Unpredictable PRN opiate, consider adjuvant End-of-dose failure Increase dose or shorten time between doses of long-acting agent

Breakthrough Pain Use immediate-release opioids 10%–15% of 24-hr dose offer after Cmax reached po  q 1hr or 50% regular 4 hour dose Do NOT use extended-release opioids

Our Case Oxycodone 120mg/24 hours 10-15% Oxycodone 15mg PO q 1 hour PRN breakthrough pain

Follow-up Oxycodone ER 120mg q 12 hours Oxycodone 15mg breakthrough 3 weeks later EPIC in-box Has taken 4 breakthrough doses daily x 2 days Re-evaluate pain 60mg additional oxycodone Increase oxycodone ER to 150mg q 12 hours New breakthrough dose? Oxycodone 30mg q 1 hours PRN

Bowel regimen

Final Thoughts Physical pain is the most common source of “suffering”

Total Pain Dame Cicely Saunders Physical Emotional Social Spiritual

Questions?